Get to know our retained experts.

Maureen Doolan Boyle

Ms. Boyle is considered one of the nation’s leading authorities on higher order multiple births and premature infant health and development and is quoted frequently in national and international newspapers, magazines and books. She is one of the founding members and the Executive Director of MOST (Mothers of Supertwins), Inc. founded in 1987 whose mission is to advocate for quality prenatal care, promote healthy deliveries, and supply information to all multiple birth families in order to support successful parenting through every phase of their children's development. Maureen is the author of The NICU Notebook: A Parents Journal and contributor to several books including Expecting Multiples: A Comprehensive Guide for Expectant Parents of Triplets, Quadruplets, Quintuplets, Sextuplets or More. Over the past two decades Ms. Boyle represented families at FDA hearings and ACOG (American College of Obstetricians and Gynecologists) presentations. She was a part of the writing and introduction of the Safe Motherhood Act to Congress in 1996. Ms. Boyle won several awards for her work on behalf of multiple birth families and babies born pre-term, including the 1999 March of Dimes Women of Distinction award. Most recently Ms. Boyle represented parents of preemies and multiples with the American Academy of Pediatrics (AAP) and on the National Leadership Committee of the Premature Infant Health Coalition under HMHB. She has also served on the International Society of Twins Studies: Council of Multiple Birth Organizations in the development of a Declaration of Rights and Statement of Needs of Twins and Higher Order Multiples.

Evelyn B. Burde, R.N., M.B.A.

Ms. Burde is an accomplished business and clinical professional in the health care industry. Her experience includes leading the creation of the clinical resource management program at the Hospital of the University of Pennsylvania, where she developed and implemented the case management system and represented the hospital in appeals of third party payor coverage and payment decisions. In this role, Ms. Burde communicated directly with third party payors and managed care organizations to justify medical necessity, obtain approval of hospital days and obtain reimbursement or prevent denials or reductions in reimbursement. Ms. Burde also devoted several years of her career consulting on coding on behalf of providers, seeking to optimize reimbursement for outpatient and ancillary services. During this time she developed manuals and training programs on coverage and reimbursement. Ms. Burde has also served as the Chief Medical Claims Examiner of one of the nation’s largest health insurers and as a practicing nurse. Ms. Burde received her B.S.N. from Thomas Jefferson University and her M.B.A. from Temple University.

Marjorie Schulman, MD

In addition to her academic roles as a professor of pediatrics, Dr. Marjorie Schulman brings 12 years of experience at Aetna, serving most recently as Senior Medical Director for National Accounts. Her expertise in neonatology and pediatrics as well as in health benefits administration, sales support and data analytics have already proved invaluable to MCL. She is currently an Associate Professor of Clinical Pediatrics at Albert Einstein College of Medicine and an Adjunct Associate Clinical Professor of Pediatrics at Touro College of Osteopathic Medicine. Dr. Schulman is a graduate of Harvard College and New York University School of Medicine. She completed her residency and fellowship at New York Hospital, Cornell Medical Center.

Mark A. Strollo, RPh, MS

Mr. Strollo advises MCL on certain aspects regarding the development and implementation of MCL’s infrastructure, operations and product delivery. In addition to his responsibilities for MCL, Mr. Strollo leads the group that develops healthcare payor strategies for Apogenics. He is a senior level pharmacy executive with extensive managed care contracting experience in the areas of specialty pharmacy and payor operations. For nearly a decade Mr. Strollo directed drug policy and utilization review for the State of New Jersey. He is nationally recognized as a visionary thinker with a strong aptitude for the recognition and application of best practices. He develops collaborative teams, efficient operations and strong partnerships with business clients to apply these practices. He drives business growth through excellence in communication, negotiation, process development, process implementation, performance enhancement and on-time results. He is widely sought to consult on areas of his technical expertise, including development of managed care benefits and medical benefits, as well as the linkage between medical and pharmacy benefits for injectable and infused medications. He was the first managed care pharmacy director to implement a closed and infused drugs program. He serves as a skilled communicator, consultant, seminar leader and as an expert witness in State Courts. He is an adjunct faculty member and is a preceptor for prominent university pharmacy programs.